Dr Reddy's Labs Q4 Results : Cons PAT jumps 22% to Rs 1,594 crore ; Rs 8 per share dividend (...)
Dr Reddy's Labs Q4 Results: Dr Reddy's Laboratories on Friday reported a consolidated net profit growth of 22% to Rs 1,594 crore in Q4FY25 versus Rs 1,307 crore reported in the year ago period.
Site référencé: The Economic Times
The Economic Times
Sebi proposes allowing investment advisers, analysts to use liquid MFs for deposit requirements
9/05/2025
Birla Corporation Q4 Results : Cons PAT rises 32% to Rs 256 crore
9/05/2025
Manappuram posts Rs 203 crore loss on Asirvad stress, names new CEO
9/05/2025
Cholamandalam Financial Holdings report consolidated Q4 PAT at Rs 1,362.18 cr
9/05/2025
Sebi mulls tweaking disclosure format for corporate governance framework by HVDLEs
9/05/2025
Defence stocks set to rally on export hopes amid rising India-Pakistan tensions : Ashika Equity
9/05/2025
